These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. An objective morphologic parameter to aid in the diagnosis of flat urothelial carcinoma in situ. Milord RA, Lecksell K, Epstein JI. Hum Pathol; 2001 Sep; 32(9):997-1002. PubMed ID: 11567231 [Abstract] [Full Text] [Related]
33. [Studies on multiple mucosal biopsy in patients with bladder cancer. 1. Evaluation of the results of multiple mucosal biopsy in patients with bladder cancer and in vivo methylene blue staining]. Igawa M. Hinyokika Kiyo; 1986 Nov; 32(11):1617-31. PubMed ID: 2435127 [Abstract] [Full Text] [Related]
36. Flat intraurothelial lesions of the urinary bladder-do hyperplasia, dysplasia, and atypia of unknown significance need to exist as diagnostic entities? and how to handle in routine clinical practice. Paner GP, Smith SC, Hartmann A, Agarwal PK, Compérat E, Amin MB. Mod Pathol; 2022 Oct; 35(10):1296-1305. PubMed ID: 35468997 [Abstract] [Full Text] [Related]
37. [Pathologic diagnosis and management of flat lesions of urothelium detected with aminolevulinic acid (Hexvix®)]. Compérat E, Conort P, Rouprêt M, Camparo P, Mazerolles C. Prog Urol; 2011 Mar; 21(3):157-65. PubMed ID: 21354032 [Abstract] [Full Text] [Related]